GlassScriptPhysician profile
Michael Ray Mcmullan
NPI 1104857036
$7,754.08
in general payments reported to CMS, 2019-2025
44 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $519 · 2021: $894 · 2022: $1,339 · 2023: $1,227 · 2024: $1,350 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,814.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $730.94 | 2019-2025 | |
| Boston Scientific Corporation | $711.47 | 2021-2025 | Watchman Access System, Avvigo Guidance System, Cds - Mct/Cem Monitoring |
| Abiomed | $666.98 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $594.71 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $456.54 | 2019-2025 | |
| Inari Medical, INC. | $317.16 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $305.03 | 2019-2023 | Brilinta |
| Medtronic, INC. | $297.62 | 2021-2025 | Mc3 Crescent Jugular Dual Lumen Catheter, Hawkone |
| Philips North America LLC | $279.75 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $262.04 | 2020-2023 | Xarelto |
| Novo Nordisk INC | $261.48 | 2024-2025 | Wegovy |
| Irhythm Technologies, INC. | $239.57 | 2021-2023 | Zio Xt Patch |
| Penumbra, INC. | $230.38 | 2022-2024 | Indigo System |
| Edwards Lifesciences Corporation | $152.09 | 2024-2025 | Evoque, Sapien 3 Ultra Resilia |
| Acist Medical Systems, INC. | $149.45 | 2023 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $145.57 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $143.03 | 2020-2024 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $141.07 | 2025 | Evkeeza |
| Abbott Laboratories | $135.97 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Livanova USA, INC. | $133.57 | 2023 | Lifesparc |
| Lantheus Medical Imaging, INC. | $131.38 | 2019 | |
| Heartflow, INC. | $120.77 | 2024 | |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Bayer Healthcare Pharmaceuticals INC. | $106.58 | 2022-2023 | |
| Amgen INC. | $102.31 | 2019-2022 | |
| Btg International INC. | $100.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $95.96 | 2019 | |
| Inspire Medical Systems, INC. | $87.39 | 2024-2025 | Inspire |
| Impulse Dynamics (USA) INC. | $84.14 | 2022-2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $73.36 | 2022-2024 | Camzyos |
| Stryker Corporation | $72.81 | 2025 | Artix Mt, Clottriever Bold Catheter, Flowtriever |
| Merck Sharp & Dohme LLC | $58.94 | 2024-2025 | Verquvo, Winrevair |
| Cardiva Medical, INC. | $41.03 | 2024-2025 | Cardiva Vascade 6/7f Vcs |
| Imperative Care, INC | $30.29 | 2025 | Symphony Catheter |
| Shockwave Medical, INC | $28.40 | 2025 | |
| Alnylam Pharmaceuticals INC. | $28.11 | 2025 | Amvuttra |
| Braemar Manufacturing, LLC | $22.75 | 2019 | |
| Bridgebio Pharma, INC. | $20.07 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $16.68 | 2024 | Arcalyst |
| Biotronik INC. | $16.60 | 2019 | |
| Akcea Therapeutics, INC. | $15.22 | 2020 | |
| Scpharmaceuticals INC. | $13.47 | 2024 | |
| Vifor Pharma, INC. | $12.89 | 2020 | |
| Ge Healthcare | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcmullan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.